TNF and COVID-19: Plasma sampling from patients with severe COVID-19 has revealed high circulating levels of immune-inflammatory markers such as interleukin (IL)-6, IL-1β, IL-2, IL-7, IL-17, and tumor necrosis factor (TNF)-α; this is also the reason behind the anti-inflammatory treatments used for COVID-19 pneumonia.